Table 4 Treatment of MLPED eyes.
From: De-novo multilayering in fibrovascular pigment epithelial detachment
Treatment | Eyes (%) |
|---|---|
PDT | 6 (35.29%) |
Intravitreal pharmacotherapy | |
Ranibizumab | 7 (41.17) |
Aflibercept | 1 (5.88) |
Bevacizumab | 0 (0) |
Ranibizumab + Aflibercept | 4 (23.5) |
Ranibizumab + Bevacizumab | 2 (11.76) |
Ranibizumab + Bevacizumab + Aflibercept | 3 (17.64) |
